封面
市場調查報告書
商品編碼
1687649

血小板凝集設備市場規模、佔有率及成長分析(按產品、應用、最終用戶和地區)-2025-2032 年產業預測

Platelet Aggregation Devices Market Size, Share, and Growth Analysis, By Product (Systems, Reagents), By Application (Clinical Applications, Research Applications), By End User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2023 年全球血小板凝集設備市場規模為 5.5291 億美元,預計將從 2024 年的 5.9051 億美元成長到 2032 年的 9.9953 億美元,預測期內(2025-2032 年)的複合年成長率為 6.8%。

由於目標疾病盛行率上升和老年人口成長,全球市場正在經歷強勁成長。此外,血小板凝集檢測(對於檢測血小板功能和相關疾病至關重要)的技術創新也在推動市場發展。此外,臨床研究和產學合作的快速增加也推動著技術創新和市場擴張。然而,醫療保健程序限制、美國醫療保健體系改革不利以及熟練專業人員短缺等挑戰可能會阻礙這一成長軌跡。總體而言,市場前景依然樂觀,但應對這些挑戰對於維持長期成長至關重要。

目錄

介紹

  • 調查目的
  • 研究範圍
  • 定義

調查方法

  • 資訊採購
  • 二次資料和一次資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分機會分析

市場動態與展望

  • 市場概覽
  • 市場規模
  • 市場動態
    • 促進因素和機會
    • 限制與挑戰
  • 波特的分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024年)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 監管格局

血小板凝集設備市場規模(依產品及複合年成長率)(2025-2032)

  • 市場概覽
  • 系統
  • 試劑
  • 耗材及配件

血小板凝集設備市場規模(依應用)及複合年成長率(2025-2032)

  • 市場概覽
  • 臨床應用
  • 研究用途

血小板凝集設備市場規模(按最終用戶和複合年成長率) (2025-2032)

  • 市場概覽
  • 醫院和診所
  • 診斷實驗室
  • 研究和學術機構
  • 其他

血小板凝集設備市場規模(按地區)及複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024年)
  • 主要企業簡介
    • 公司詳情
    • 產品系列分析
    • 公司分部佔有率分析
    • 收益與前一年同期比較對比(2022-2024 年)

主要企業簡介

  • F. Hoffmann-La Roche Ltd.(Switzerland)
  • Siemens Healthineers AG(Germany)
  • Haemonetics Corporation(USA)
  • Sysmex Corporation(Japan)
  • Helena Laboratories Corporation(USA)
  • Chrono-Log Corporation(USA)
  • Drucker Diagnostics(USA)
  • Werfen(Spain)
  • Aggredyne, Inc.(USA)
  • Sentinel CH. SpA(Italy)
  • Tem Group(Germany)
  • LSI Medience Corporation(Japan)
  • Matis Medical Inc.(USA)
  • Hart Biologicals(UK)

結論和建議

簡介目錄
Product Code: SQMIG35A2823

Global Platelet Aggregation Devices Market size was valued at USD 552.91 million in 2023 and is poised to grow from USD 590.51 million in 2024 to USD 999.53 million by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).

The global market is witnessing robust growth, fueled by the rising prevalence of targeted diseases and a growing geriatric population. Technological innovations in platelet aggregometry, critical for examining platelet function and associated disorders, are also enhancing market momentum. Furthermore, an increase in collaborations between industry and academia, along with a surge in clinical studies, is driving innovation and market expansion. However, challenges such as procedural constraints in healthcare, adverse reforms within the U.S. healthcare system, and a shortage of skilled professionals may hinder this growth trajectory. Overall, while the market outlook remains positive, addressing these challenges will be crucial for sustaining growth in the long term.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Platelet Aggregation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Platelet Aggregation Devices Market Segments Analysis

Global Platelet Aggregation Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Systems, Reagents and Consumables and Accessories. Based on Application, the market is segmented into Clinical Applications and Research Applications. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Platelet Aggregation Devices Market

The global platelet aggregation devices market is poised for significant growth driven by the rising demand for these essential diagnostic tools. This surge is largely influenced by the increasing incidence of chronic diseases and bleeding disorders worldwide, which necessitate effective monitoring and management solutions. As the prevalence of such medical conditions escalates, the need for advanced diagnostic capabilities becomes critical, with platelet aggregation devices at the forefront of this evolution. These devices are vital for evaluating platelet function, thereby facilitating the diagnosis and treatment of various coagulation-related disorders. This growing reliance on advanced technology is expected to create ample opportunities for market stakeholders.

Restraints in the Global Platelet Aggregation Devices Market

The growth of the global platelet aggregation devices market is hindered by several significant challenges, primarily the high costs associated with these advanced diagnostic tools and a shortage of qualified personnel. The considerable investment required to purchase platelet aggregation devices can deter healthcare organizations and facilities from incorporating them into their operations, limiting access to these technology-driven solutions. Additionally, the lack of trained staff hampers the effective usage and maintenance of the devices, further exacerbating the situation. Consequently, these factors collectively restrain the expansion of the market and the widespread adoption of essential platelet aggregation technologies.

Market Trends of the Global Platelet Aggregation Devices Market

The Global Platelet Aggregation Devices market is witnessing a significant upward trend, spurred by the increasing incidence of hemostasis disorders worldwide. As healthcare professionals emphasize the importance of accurate platelet aggregation testing for diagnosing various bleeding and coagulation disorders, the demand for these specialized devices is rapidly expanding. The growing awareness of the critical role that platelet function plays in therapeutic monitoring and clinical decision-making is further fueling market growth. Moreover, advancements in technology and the development of user-friendly, highly sensitive devices are enhancing their clinical utility. As hemostatic issues become more prevalent, the platelet aggregation devices market is projected to see sustained growth through the forecast period, underscoring its vital role in modern healthcare diagnostics.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape

Global Platelet Aggregation Devices Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Systems
  • Reagents
  • Consumables and Accessories

Global Platelet Aggregation Devices Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Clinical Applications
  • Research Applications

Global Platelet Aggregation Devices Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research and Academic Institutes
  • Others

Global Platelet Aggregation Devices Market Size & CAGR (2025-2032)

  • North America (Product, Application, End User)
    • US
    • Canada
  • Europe (Product, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • F. Hoffmann-La Roche Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Haemonetics Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Helena Laboratories Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chrono-Log Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Drucker Diagnostics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Werfen (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aggredyne, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sentinel CH. SpA (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tem Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LSI Medience Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Matis Medical Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hart Biologicals (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations